We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
6 own
4 watching
Current Price
$0
$0.52
(0.88%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
1,892.09M
52-Week High
61.3
52-Week Low
10
Average Volume
0.08M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,892.09M
52-Week High61.3
52-Week Low10
Average Volume0.08M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Ticker Report
1month ago
TransMedics Group, Inc. (NASDAQ:TMDX Get Rating) CFO Stephen Gordon sold 10,000 shares of TransMedics Group stock in a transaction that occurred on Monday, October 3rd. The shares were sold at an average price of $41.74, for a total transaction of $417,400.00. Following the completion of the...
PR Newswire
3 months ago
TransMedics Announces Upsize and Pricing of Public Offering of Common Stock TransMedics Announces Upsize and Pricing of Public Offering of Common Stock PR Newswire ANDOVER, Mass., Aug. 4, 2022 ANDOVER, Mass., Aug. 4, 2022 /PRNewswire/ -- TransMedics Group, Inc. ('TransMedics') (Nasdaq...
Ticker Report
7 months ago
TransMedics Group, Inc. (NASDAQ:TMDX Get Rating)s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $22.63, but opened at $25.00. TransMedics Group shares last traded at $22.84, with a volume of 71 shares traded. TMDX has been the subject of a ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.52
(0.88%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00